HISTONE ACETYLTRANSFERASE P300/CBP-ASSOCIATED FACTOR INHIBITION BY QUERCETIN AS ANTICANCER DRUG CANDIDATE WITH IN SILICO AND IN VITRO APPROACH
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2016, Vol 8, Issue 5
Abstract
Objective: The objective of this research was to show quercetin potency to inhibit histone acetyltransferase p300/CBP-associated factor (HAT PCAF) activity. Molecular docking study was used to show inhibition model of quercetin towards HAT PCAF and the kinetic study was used to give the information about inhibition constant (Ki) of quercetin.Methods: Molecular docking simulations between HAT and quercetin were performed using AutoDock Vina, and the results were scored based on its Gibbs free energy change (ΔG) (the most negative ΔG). The kinetic assay of HAT PCAF inhibition by quercetin used fluorometry methods to measure enzyme inhibition by quercetin. Results: Molecular docking showed that quercetin could inhibit HAT PCAF through binding to acetyl-CoA that involved glutamine 525 (Gln525) and cysteine 574 (Cys574) on chain A, and Cys574 and Gln581 on chain B of HAT PCAF. Quercetin also binds to histone active site on HAT PCAF through aspartic acid 610 (Asp610). The kinetic study results showed that quercetin could inhibit histone acetylation based on the fluorescence intensity. Analysis by Dixon plot showed that quercetin competes with histone. Therefore, ithad competitive inhibition. Its Ki value of 9.575 µM. Kinetic study showed the same result as molecular docking study that quercetin had potency as an HAT PCAF inhibitor.Conclusion: The result of this research showed that quercetin had the potency to inhibit HAT PCAF through competition with HAT PCAF substrates. Quercetin could interact with the HAT PCAF active site, thus, lower the HAT PCAF activity. Keywords: Histone acetyltransferase, Quercetin, PCAF, Epigenetic drug, Docking
Authors and Affiliations
Rabiatul Adawiyah, Suryani . , I Made Artika
Keywords
Related Articles
- EP ID EP577638
- DOI -
- Views 57
- Downloads 0
EVALUATION OF REPEATED DOSE-90-DAY ORAL TOXICITY STUDY OF L-DOPA AND HYOSCINE HYDRBROMIDE COMBINATION IN RATS
Objective: The present study was done to evaluate repeated-dose 90-day oral toxicity studies of l-dopa and hyoscine hydrbromide combination in rats. Methods: Repeated-dose 90-day oral toxicity study was performed accordi...
EVIDENCES FOR THE PROMISING THERAPEUTIC POTENTIAL OF BOSWELLIA SERRATA AGAINST ALZHEIMER'S DISEASE: PRE-CLINICAL STUDY
Objective: The current study was planned to investigate the anti-inflammatory and antiapoptotic effects of Boswellia serrata methanolic extract against neurodegeneration characterizing Alzheimer’s disease (AD) in rat m...
ANTIOXIDANT AND FREE RADICAL SCAVENGING CAPACITY OF RED SEAWEED HYPNEA VALENTIAE FROM RAMESHWARAM COAST TAMIL NADU, INDIA
Objectives: In this study, In-vitro antioxidant and free radical scavenging activity of Hypnea valentiae was evaluated in a series of in vitro assays. Antioxidants are vital substances which possess the ability to protec...
NANOPRECIPITATION TECHNIQUE FOR PREPARATION OF STERICALLY STABILIZED RISPERIDONE NANOSUSPENSION: IN VITRO AND IN VIVO STUDY
Objective: Risperidone is an atypical antipsychotic drug used to treat schizophrenia; however it suffers from a poor aqueous solubility, which delays its onset of action. Therefore, the purpose of the present study is to...
DEVELOPMENT AND VALIDATION OF UV SPECTROMETRIC METHOD FOR QUANTITATIVE DETERMINATION OF ULIPRISTAL ACETATE
Objective: To develop and validate UV spectrometric method for quantitative determination of ulipristal acetate.Methods: The solvent selected was methanol and detection was carried out at 302 nm.Results: Linearity of the...